Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

فلترة النتائج

Publisher : boston children's hospital

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Report

A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB

Authors : Alcresta Therapeutics, Inc.; Mark Puder, MD, PhD, Professor Pediatric General Surgery

Source: A 90 Day Observational Study as an Extension to the Phase 3, Open Labeled, Exploratory Study of RELiZORB to Evaluate Safety, Tolerability, and Nutrient Absorption in Children With Short Bowel Syndrome

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Report

A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

Authors : Alcresta Therapeutics, Inc.; Mark Puder, MD, PhD, Professor Pediatric General Surgery

Source: A 90 Day, Phase 3, Open Labeled Exploratory Study of RELiZORB to Evaluate Safety, Tolerability, and Nutrient Absorption in Children With Short Bowel Syndrome Who Are Dependent on Parenteral

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي